Publication | Closed Access

A phase III comparison of CHOP vs. m-BACOD vs. ProMACE-CytaBOM vs. MACOP-B in patients with intermediate- or high-grade non-Hodgkin's lymphoma: Results of SWOG-8516 (Intergroup 0067), the National High-Priority Lymphoma Study

Hematological MalignancyLymphoid NeoplasiaSurgical OncologyMedicinePathologyHigh-grade Non-hodgkinIntergroup 0067OncologyRadiation OncologyCancer ResearchPhase Iii Comparison